Global Labeling 2014: Compliance in a Changing Regulatory Environment

Featured

Want to learn more about Global Labeling 2014: Compliance in a Changing Regulatory Environment? You've come to the right site!

To keep you at the forefront.

Essential Labeling Tools:

Global Labeling for Medical Devices, Labeling Compliance Self Audits and Plain Language Writing for Labeling Professionals

Essential Labeling Tools:

Global Labeling for Medical Devices, Labeling Compliance Self Audits and Plain Language Writing for Labeling Professionals

Steven Bass, PHD President
United States
Su-Yueh Lin Sr. Labeling Consultant, Regulatory Affairs
SYL Regulatory Consulting, Taiwan
Bruce Boulton, MSC Product Information Officer, Bureau Gastroenterology, Infection & Viral Diseases
Health Canada, Canada
Mark Collins, PHD, MBA Principal Consultant
Opus Regulatory, United States
Barbara J. Fanelli, MSC Associate Adjunct Professor
Temple University School of Pharmacy, United States
A. Leander Fontaine, MD President
Pharmiceutics, LLC., United States
Rie Matsui, RPH Senior Director, Regional Labeling Head for APAC
Pfizer R&D Japan G.K., Japan
Gerrit Nijveldt, MS, MSC Global Labeling Consultant
Opus Regulatory, United States
Barbara Lachmann, MD Sole Proprietor
Barbara Lachmann Labeling Consulting, Germany
Megann Looker Executive Director, Head of Global Labeling
Jazz Pharmaceuticals, United Kingdom
Julie P. Retzinger, MBA, RN Senior Director - Global Labeling and CCDS
Astellas Pharma Inc., United States
Junko Sato, PHD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan